MANA Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,427
Closed -$223K 131
2020
Q2
$223K Buy
+2,427
New +$233K 0.96% 58
2020
Q1
Sell
-4,500
Closed -$511K 70
2019
Q4
$511K Buy
+4,500
New +$494K 1.7% 6
2019
Q3
Sell
-6,930
Closed -$675K 161
2019
Q2
$675K Buy
6,930
+2,460
+55% +$225K 1.49% 6
2019
Q1
$407K Buy
4,470
+860
+24% +$77K 1.32% 14
2018
Q4
$328K Sell
3,610
-289
-7% -$27K 2.11% 14
2018
Q3
$384K Buy
3,899
+705
+22% +$65.2K 1.75% 13
2018
Q2
$273K Buy
+3,194
New +$267K 1.46% 33
2018
Q1
Sell
-17,000
Closed -$1.37M 302
2017
Q4
$1.37M Buy
+17,000
New +$1.36M 0.59% 33

Other funds holding MDT

MANA Advisors's MDT Position: Q3 2020 in Review

MANA Advisors sold out of Medtronic (MDT) in Q3 2020, closing a stake of 2,427 shares — an estimated $223K sold.

MANA Advisors first reported a position in MDT in Q4 2017 and held it in 8 quarters. The position peaked at $1.37M in Q4 2017. 1,811 funds tracked by Wall St. Rank hold MDT as of Q3 2020.

  • MANA Advisors reported no remaining Medtronic position as of Q3 2020 after selling out during the quarter.
  • MANA Advisors sold 2,427 Medtronic shares in Q3 2020, an estimated $223K.
  • MANA Advisors first reported a position in Medtronic in Q4 2017 and held it in 8 quarters.
  • MANA Advisors's Medtronic position peaked at $1.37M in Q4 2017.
  • 1,811 funds tracked by Wall St. Rank held Medtronic as of Q3 2020.

Based on MANA Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.